IP Issues | Association for Accessible Medicines
CBS News - How critics say drug companies play "games" to stave off generic competitors.

IP Issues

AAM White Paper: Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents

For more than four decades, U.S. Patent and Trademark Office (PTO) review of issued patents has been considered a vital component of a healthy patent system, and Congress has worked to improve that review system to systematically eliminate invalid, competition-killing patents. The rental of Native American sovereign immunity by brand name drug companies is a transparent attempt to thwart this process.

Subscribe to IP Issues